Becton, Dickinson and Company (BDX)
NYSE$232.12
Market Cap
$66.65B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
198 of 924
Rank in Industry
12 of 47
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
BDX Insider Trading Activity
BDX Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $350,430 | 1 | 6 |
Sells | $5,579,787 | 15 | 94 |
Related Transactions
| Henderson Jeffrey William | director | 1 | $350,430 | 0 | $0 | $350,430 |
| Spoerel Thomas J | SVP,Controller&Chief Acct Off | 0 | $0 | 1 | $71,793 | $-71,793 |
| SCOTT BERTRAM L | director | 0 | $0 | 1 | $159,593 | $-159,593 |
| Byrd Richard | EVP & President Interventional | 0 | $0 | 1 | $436,325 | $-436,325 |
| Shan David | EVP and Chief ISC Officer | 0 | $0 | 2 | $450,375 | $-450,375 |
| Neal Shana Carol | EVP and Chief People Officer | 0 | $0 | 3 | $594,550 | $-594,550 |
| Garrison Michael David | EVP & President Medical | 0 | $0 | 3 | $1.17M | $-1.17M |
| Goette Roland | EVP and President EMEA | 0 | $0 | 4 | $2.69M | $-2.69M |
About Becton, Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer …
Insider Activity of Becton, Dickinson and Company
Over the last 12 months, insiders at Becton, Dickinson and Company have bought $350,430 and sold $5.58M worth of Becton, Dickinson and Company stock.
On average, over the past 5 years, insiders at Becton, Dickinson and Company have bought $350,430 and sold $4.25M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Henderson Jeffrey William (director) — $350,430.
The last purchase of 1,500 shares for transaction amount of $350,430 was made by Henderson Jeffrey William (director) on 2025‑02‑10.
List of Insider Buy and Sell Transactions, Becton, Dickinson and Company
| 2025-03-12 | Sale | Byrd Richard | EVP & President Interventional | 1,940 0.0007% | $224.91 | $436,325 | +1.38% | |
| 2025-02-12 | Sale | SCOTT BERTRAM L | director | 700 0.0002% | $227.99 | $159,593 | -0.82% | |
| 2025-02-10 | Henderson Jeffrey William | director | 1,500 0.0005% | $233.62 | $350,430 | -1.99% | ||
| 2025-01-21 | Sale | Neal Shana Carol | EVP and Chief People Officer | 787 0.0003% | $240.00 | $188,880 | -4.98% | |
| 2025-01-21 | Sale | Shan David | EVP and Chief ISC Officer | 500 0.0002% | $240.00 | $120,000 | -4.98% | |
| 2025-01-17 | Sale | Garrison Michael David | EVP & President, Medical | 597 0.0002% | $236.51 | $141,196 | -3.76% | |
| 2025-01-07 | Sale | Neal Shana Carol | EVP and Chief People Officer | 788 0.0003% | $235.00 | $185,180 | -0.99% | |
| 2024-12-19 | Sale | Garrison Michael David | EVP & President, Medical | 2,838 0.001% | $223.33 | $633,811 | +2.08% | |
| 2024-12-09 | Sale | Goette Roland | EVP and President, EMEA | 638 0.0002% | $219.03 | $139,741 | +2.23% | |
| 2024-12-06 | Sale | Goette Roland | EVP and President, EMEA | 4,483 0.0016% | $221.01 | $990,788 | +4.05% | |
| 2024-12-06 | Sale | Neal Shana Carol | EVP and Chief People Officer | 1,000 0.0003% | $220.49 | $220,490 | +4.05% | |
| 2024-12-05 | Sale | Shan David | EVP and Chief ISC Officer | 1,500 0.0005% | $220.25 | $330,375 | +3.01% | |
| 2024-06-10 | Sale | Spoerel Thomas J | SVP,Controller&Chief Acct Off | 300 0.0001% | $239.31 | $71,793 | -2.29% | |
| 2024-05-15 | Sale | Goette Roland | EVP and President EMEA | 3,300 0.0011% | $236.73 | $781,224 | -0.98% | |
| 2024-05-13 | Sale | Goette Roland | EVP and President EMEA | 3,300 0.0011% | $236.70 | $781,121 | -0.82% | |
| 2024-04-30 | Sale | Garrison Michael David | EVP & President Medical | 1,715 0.0006% | $232.81 | $399,269 | +0.17% | |
| 2024-03-14 | Sale | Spoerel Thomas J | SVP,Controller&Chief Acct Off | 282 <0.0001% | $238.29 | $67,198 | -0.83% | |
| 2023-12-11 | Sale | Garrison Michael David | EVP & President Medical | 1,239 0.0004% | $232.46 | $288,018 | +1.87% | |
| 2023-11-28 | Sale | Byrd Richard | EVP & President Interventional | 2,156 0.0007% | $238.47 | $514,141 | +0.61% | |
| 2023-09-05 | Sale | Byrd Richard | EVP & President Interventional | 459 0.0002% | $274.48 | $125,986 | -12.04% |
Total: 405
*Gray background shows transactions not older than one year
Insider Historical Profitability
6.05%
| Henderson Jeffrey William | director | 8015 0.0028% | $1.86M | 1 | 0 | |
| OVERLOCK WILARD J JR | director | 21091 0.0073% | $4.9M | 2 | 2 | +1.24% |
| UGGLAS MARGERETHA AF | director | 10000 0.0035% | $2.32M | 1 | 0 | +22.53% |
| BURZIK CATHERINE M | director | 10007 0.0035% | $2.32M | 3 | 1 | +5.53% |
| Minehan Cathy E. | director | 3000 0.001% | $696,360.00 | 2 | 0 | +2.05% |
*Gray background shows insiders who have made transactions during last year
BDX Institutional Investors: Active Positions
| Increased Positions | 744 | +40.74% | 26M | +9.99% |
| Decreased Positions | 795 | -43.54% | 19M | -7.53% |
| New Positions | 196 | New | 5M | New |
| Sold Out Positions | 139 | Sold Out | 3M | Sold Out |
| Total Postitions | 1,775 | -2.79% | 264M | +2.47% |
BDX Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Vanguard Group Inc | $6.04M | 9.32% | 26.74M | +184,288 | +0.69% | 2024-12-31 |
| Blackrock, Inc. | $5.42M | 8.36% | 23.98M | +2M | +7.68% | 2024-12-31 |
| State Street Corp | $3.18M | 4.91% | 14.09M | +134,357 | +0.96% | 2024-12-31 |
| Price T Rowe Associates Inc /Md/ | $2.79M | 4.3% | 12.35M | -1M | -9.21% | 2024-12-31 |
| T. Rowe Price Investment Management, Inc. | $2.74M | 4.22% | 12.13M | +3M | +36.14% | 2024-12-31 |
| Morgan Stanley | $2.31M | 3.57% | 10.24M | -742,840 | -6.76% | 2024-12-31 |
| Geode Capital Management, Llc | $1.44M | 2.21% | 6.35M | +66,024 | +1.05% | 2024-12-31 |
| Massachusetts Financial Services Co /Ma/ | $1.4M | 2.15% | 6.18M | +810,345 | +15.1% | 2024-12-31 |
| Generation Investment Management Llp | $1.31M | 2.03% | 5.82M | -139,252 | -2.34% | 2024-12-31 |
| First Eagle Investment Management, Llc | $1M | 1.54% | 4.43M | +1M | +31.41% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.